Proprotein convertase subtilisin/kexin 9 (PCSK9) and lipopolysaccharide (LPS) in patients with atrial fibrillation. A biomarker post-hoc analysis from the ATHERO-AF cohort.
3 September 2019 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Sapienza University of Rome, Rome (Italy)
10 More presentations in this session
Access the full session
The Event
ESC Congress 2019
3 September 2019
08:30 CET
